- Abstract
- Core Tip
- Article Highlights
- Full Article (PDF)
- Full Article with Cover (PDF)
- Full Article (XML)
- Full Article (HTML)
- Audio
- PubMed Central
- PubMed
- CrossRef
- Google Scholar
- Similar Articles (29)
- Timeline of Article Publication (1)
- Authors Evaluation (2)
- Article Quality Tracking (1)
- Reference Citation Analysis (0)
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4760)
All Articles published online
|
Publishing Process of This Article
|
Mar 27, 2024 (publication date) through Mar 29, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Sato-Espinoza K, Chotiprasidhi P, Huaman MR, Díaz-Ferrer J. Update in lean metabolic dysfunction-associated steatotic liver disease. World J Hepatol 2024; 16(3): 452-464 [PMID: 38577539 DOI: 10.4254/wjh.v16.i3.452] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v16/i3/452.htm |
| Number | Citing Articles |
| 1 |
E. E. Zabotina, Yu. A. Khabarova, N. Yu. Stukova. Metabolic dysfunction associated steatotic liver disease in lean patients. Diagnostic and treatment challenges. Experimental and Clinical Gastroenterology 2025; (9): 96 doi: 10.31146/1682-8658-ecg-229-9-96-109
|
| 2 |
Jan Best, Julia Kälsch, Marcin Krawczyk, Paul Manka, Ali Canbay, Hartmut Schmidt, Leonie Jochheim. Metabolische Dysfunktion-assoziierte steatotische Lebererkrankung und hepatozelluläres Karzinom. Die Gastroenterologie 2025; 20(2): 123 doi: 10.1007/s11377-025-00878-z
|
| 3 |
Lampros Chrysavgis, Evangelos Cholongitas. From NAFLD to MASLD: what does it mean?. Expert Review of Gastroenterology & Hepatology 2024; 18(6): 217 doi: 10.1080/17474124.2024.2374472
|
| 4 |
Karina Sato-Espinoza, Perapa Chotiprasidhi, Estefanía Liza, Zuly Placido-Damian, Javier Diaz-Ferrer. Evolution of liver transplantation in the metabolic dysfunction-associated steatotic liver disease era: Tracking impact through time. World Journal of Transplantation 2024; 14(4): 98718 doi: 10.5500/wjt.v14.i4.98718
|